增强TREM2表达激活微质,并适度缓解tau病理和神经退行
Kai Chen1, Fuyao Li1, Shuwen Zhang2
1Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
Journal of neuroinflammation
|March 24, 2025
概括
在阿尔茨海默氏症模型中对TREM2 (触发受体表达骨髓2) 进行升级,改善了微质反应,减少了tau病理. R47H变体显示功能丧失,影响治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 触发受体表达神经质2 (TREM2) 是一种与阿尔茨海默病 (AD) 风险相关的微质特异性受体.
- TREM2影响微质对粉样蛋白病理的反应,但其在病理和神经退行症中的作用尚未完全理解.
研究的目的:
- 在小鼠模型中研究TREM2变异对病理和神经退行症的影响.
- 阐明TREM2在病情中调节微质激活的机制.
主要方法:
- 使用了PS19 tauopathy小鼠模型,可诱导野生型TREM2 (TREM2-WT) 或R47H变体 (TREM2-R47H) 的过度表达.
- 采用单细胞RNA测序来分析微质激活状态.
- 评估了可溶性酸化陶水平和神经元完整性.
主要成果:
- TREM2-WT过度表达减少了可溶性酸化,并保持了神经元的完整性.
- TREM2-WT增强了微质激活,诱导了与疾病相关的微质 (DAM) 签名.
- 过度表达TREM2-R47H表明功能丧失,对tau,神经退行或微质激活没有显著影响.
结论:
- 在调节微质活动和影响病理和神经退行方面,TREM2起着至关重要的作用.
- TREM2-WT增强了有益的微质反应,而R47H变体可能会损害这些功能.
- 研究结果提供了对阿尔茨海默病和其他病的TREM2向治疗方法的见解.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.微质细胞中的微质细胞这种R47H变体是R47H变体.在TREM2中,我们可以使用TREM2.陶氏病理学是一种病理学.文字转录学 (Transcriptomics) 是一个学科.更多相关视频
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
31.6K
06:22A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
Published on: September 3, 2021
3.6K
相关概念视频
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
